# Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

> **NCT05637086** · PHASE2 · RECRUITING · sponsor: **Mostafa Bahaa** · enrollment: 90 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Phenytoin
- **DRUG:** Pentoxifylline 400 MG
- **DRUG:** Celecoxib 200mg

## Key facts

- **NCT ID:** NCT05637086
- **Lead sponsor:** Mostafa Bahaa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-20
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-11-20
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05637086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05637086, "Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05637086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*